| Name | Title | Contact Details |
|---|
Elizabeth R. Griffin Research Foundation is a Kingsport, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Clarity Child Guidance Center exists to transform the lives of children and families. We are the only nonprofit treatment center in San Antonio and South Texas that specializes in children ages 3-17 who suffer from serious mental health problems. Our inpatient and outpatient programs include a range of services, from crisis stabilization, to psychiatric evaluations, to ongoing therapy.
Orthopaedic Specialists of North Carolina is a medical practice that provides orthopedic care and services to patients in the Raleigh, North Carolina area. They offer a patient-friendly atmosphere and use innovative and advanced technology to provide a...
LifeStream Behavioral Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. LifeStream Behavioral Center is based in Leesburg, FL. You can find more information on LifeStream Behavioral Center at www.lsbc.net
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.